The aim of this study is to evaluate the impact of SH T00658ID (EV/DNG tablet) on hemostatic parameters in comparison to a reference oral contraceptive (OC) (SH D01155E) in a crossover design.
- Healthy female volunteers
- Pregnancy or lactation - Any condition that might interfere with the outcome as all contraindications for OC use.
Groningen, Netherlands, 9713GZ
E-mail: [email protected]
Phone: Not Available
A single-centre, open-label, crossover, controlled, randomized study to investigate the impact of SH T00658ID as compared to a monophasic contraceptive containing ethinylestradiol and levonorgestrel (SH D01155E) on hemostatic parameters in 30 healthy female volunteers over 3 treatment cycles